Loading…

Browse All Grants

99,167 grants found

Filters
Reset

Showing 281300 of 99,167 grants

Completed NON-SBIR/STTR RPGS
Platform technologies for scalable highly multiplexed proteomic phenotyping of the brain
NATIONAL INSTITUTE OF MENTAL HEALTH Harvard University United States 2021 – 2025

The complexity of the mammalian brain is unparalleled by any other organs, and understanding its cellular composition and their brain-wide organization is essential to understand t...

$54.75M
USD
Active NON-SBIR/STTR RPGS
Indiana Clinical and Translational Sciences Institute
NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENC... Indiana University Indianapolis United States 2023 – 2030

PROJECT SUMMARY/ABSTRACT The Indiana Clinical and Translational Sciences Institute (Indiana CTSI) was created in 2008 as a statewide partnership to accelerate clinical and transl...

$54.75M
USD
Active NON-SBIR/STTR RPGS
CTSA UM1 Program at University of Utah
NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENC... University of Utah United States 2023 – 2030

ABSTRACT The vision of the Utah Clinical & Translational Science Institute (CTSI) is to strategically and ethically develop and apply generalizable and reproducible clinical and...

$54.62M
USD
Active NON-SBIR/STTR RPGS
Delaney AIDS Research Enterprise to Cure HIV
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... University of California, San Francisco United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT The goals of the DARE Collaboratory are to develop a viable combination regimen that reduces the rebound- competent HIV/SIV reservoir during antiretrovir...

$54.56M
USD
Active NON-SBIR/STTR RPGS
Delaney AIDS Research Enterprise to Cure HIV
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... University of California, San Francisco United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT The goals of the DARE Collaboratory are to develop a viable combination regimen that reduces the rebound- competent HIV/SIV reservoir during antiretrovir...

$54.52M
USD
Completed NON-SBIR/STTR RPGS
The role of 24-hour activity cycles in preserving cognitive function and preventing Alzheimer's disease and related dementias
NATIONAL INSTITUTE ON AGING Columbia University Health Sciences United States 2022 – 2025

ABSTRACT Alzheimer’s disease and related dementias (ADRD) are the 6th leading cause of death in the U.S and is prevalent in ~6 million U.S. adults. Without effective prevention s...

$54.5M
USD
Active NON-SBIR/STTR RPGS
Delaney AIDS Research Enterprise to Cure HIV
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... University of California, San Francisco United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT The goals of the DARE Collaboratory are to develop a viable combination regimen that reduces the rebound- competent HIV/SIV reservoir during antiretrovir...

$54.49M
USD
Active NON-SBIR/STTR RPGS
Pediatric Adolescent Virus Elimination (PAVE) Martin Delaney Collaboratory
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Johns Hopkins University United States 2021 – 2026

ABSTRACT The immediate establishment of the latent HIV-1 reservoir in resting memory CD4+ T cells precludes HIV-1 cure, compelling ART for a lifetime in children. The mission of...

$54.48M
USD
Active NON-SBIR/STTR RPGS
Indiana Clinical and Translational Sciences Institute
NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENC... Indiana University Indianapolis United States 2023 – 2030

PROJECT SUMMARY/ABSTRACT The Indiana Clinical and Translational Sciences Institute (Indiana CTSI) was created in 2008 as a statewide partnership to accelerate clinical and transl...

$54.27M
USD
Active NON-SBIR/STTR RPGS
CTSA UM1 Program at University of Utah
NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENC... University of Utah United States 2023 – 2030

ABSTRACT The vision of the Utah Clinical & Translational Science Institute (CTSI) is to strategically and ethically develop and apply generalizable and reproducible clinical and...

$54.25M
USD
Active NON-SBIR/STTR RPGS
Vascular-immune mechanisms of cerebral amyloid angiopathy and Alzheimer's pathology
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND S... J. David Gladstone Institutes United States 2024 – 2027

Cognitive decline in the aging brain is driven by overlapping neurodegenerative and cerebrovascular pathologies. Over 80% of Alzheimer's disease (AD) patients co-present with cereb...

$54.24M
USD
Active NON-SBIR/STTR RPGS
Enterprise for Research and Advocacy to Stop and Eradicate HIV (ERASE-HIV)
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Emory University United States 2021 – 2026

Abstract The presence of a reservoir of cells harbouring integrated, replication-competent virus that persists under long- term, fully suppressive antiretroviral therapy (ART) an...

$54.12M
USD
Completed NON-SBIR/STTR RPGS
CVL-354, a kappa opioid receptor antagonist for treatment of opioid use disorder, withdrawal and relapse
NATIONAL INSTITUTE ON DRUG ABUSE Cerevel Therapeutics, Llc United States 2021 – 2023

PROJECT SUMMARY Kappa opioid receptors (KOR) are expressed in brain areas that control reward, motivation, and anxiety. Dynorphin (DYN), an endogenous KOR agonist controls KOR acti...

$54M
USD
Completed NON-SBIR/STTR RPGS
Multi-morbidity 3-City Alzheimer's Disease EHR Study (M3AD Study)
NATIONAL INSTITUTE ON AGING Columbia University Health Sciences United States 2024 – 2025

The overall goal of our proposal is to place patients impacted by Alzheimer’s Disease (AD) and Related Dementia (AD/ADRD), rather than the disease, at the center of the research i...

$53.87M
USD
Active NON-SBIR/STTR RPGS
The Rhythm Evaluation for Anticoagulation with Continuous Monitoring of Atrial Fibrillation Trial (REACT-AF)
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE Northwestern University At Chicago United States 2022 – 2029

Project Summary / Abstract Purpose: The Rhythm Evaluation for AntiCoagulaTion with Continuous Monitoring of Atrial Fibrillation (REACT AF) clinical trial will compare the efficac...

$53.74M
USD
Active NON-SBIR/STTR RPGS
REACH: Research Enterprise to Advance a Cure for HIV
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... Weill Medical Coll of Cornell Univ United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Despite the success of standard antiretroviral therapy (ART), the need for an HIV cure remains compelling, both to improve the lives of PWH and to bring...

$53.72M
USD
Completed NON-SBIR/STTR RPGS
Development of Lofexidine as a First-line Non-Opioid Pharmacologic Treatment for Neonatal Opioid Withdrawal Syndrome
NATIONAL INSTITUTE ON DRUG ABUSE Uswm, Llc United States 2021 – 2025

PROJECT SUMMARY: An alarming increase in the rate of opioid abuse among the general population has resulted in a public health emergency since 2017. The striking rise in opioid use...

$53.53M
USD
Completed NON-SBIR/STTR RPGS
Development of a Potent and Selective Nav1.8 inhibitor for the Treatment of Acute and Chronic Pain with the Goal of Reducing Opioid Use and Preventing Opioid Use Disorders
NATIONAL INSTITUTE ON DRUG ABUSE Siteone Therapeutics, Inc. United States 2023 – 2025

PROJECT SUMMARY Voltage-gated sodium ion channels (NaVs) are required for the transmission of electrical signals along pain sensing neurons. While a number of NaV isoforms are ex...

$53.42M
USD
Active NON-SBIR/STTR RPGS
HOPE - HIV Obstruction by Programmed Epigenetics
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... J. David Gladstone Institutes United States 2021 – 2026

PROJECT SUMMARY/ABSTACT After 40 years, a cure for people living with HIV (PLWH) remains both elusive and one of NIAID/NIH’s highest priorities. Rebound-competent latent reservoi...

$53.36M
USD
Active NON-SBIR/STTR RPGS
HOPE - HIV Obstruction by Programmed Epigenetics
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEA... J. David Gladstone Institutes United States 2021 – 2026

PROJECT SUMMARY/ABSTACT After 40 years, a cure for people living with HIV (PLWH) remains both elusive and one of NIAID/NIH?s highest priorities. Rebound-competent latent reservoir...

$53.36M
USD